Trisomy 21 Clinical Trial
Official title:
Non-invasive Screening of Fetal Trisomy 21 by Digital PCR
In France, as in many countries of the world, trisomy 21 or Down syndrome (DS) is the subject of an antenatal screening based on a risk calculation (R) including the assay of biochemical markers in the maternal blood, and the measurement of a fetal ultrasound parameter (nuchal translucency). In the population of pregnant women said to be at high risk (R> 1/250), confirmation of the diagnosis of DS is made by invasive sampling (trophoblast biopsy or amniocentesis), which allows the establishment of fetal karyotype. In addition to limited sensitivity (80 to 85% depending on the techniques), this screening is an anxiety factor (8% false positives), and miscarriages of euploid fetuses (normal karyotype) in 1% of cases (procedures invasive). The plasma of a pregnant woman contains a mixture of free DNA of maternal (90%) and fetal origin (cffDNA for cell free fetal DNA) (about 10%, but this proportion increases in cases of fetal trisomy 21. The proportion of cffDNA is sufficient to qualitatively and quantitatively study specific genetic markers of a pair of chromosomes. It is therefore possible to evaluate the quantity of markers chromosome of interest relative to a reference chromosome marker, and to calculate a marker / marker ratio of interest, theoretically identical for all autosomes (chromosomes 1 to 22) during euploid pregnancy. In case of fetal aneuploidy (for example, trisomy 21), this ratio is unbalanced for the chromosomal pair involved. Advances in technology, such as high-throughput mass sequencing (MPS) and digital PCR (dPCR), now make it possible to consider the diagnosis of fetal maternal DS through the study of cffDNA. Several teams have already published on this subject with the MPS technique, applied directly to free DNA from maternal plasma, or after a cffDNA isolation step. This involves sequencing the DNA fragments present in the sample and placing them back on their original chromosome. In case of trisomy 21 fetal, one seeks to put in evidence of an excess of sequences from chromosome 21. These techniques require expensive equipment (sequencer, bioinformatic platform, servers) and a technical time and important analysis (often several days for a single run). Concerning the research of aneuploidies by digital PCR (dPCR), few publications are today due to the absence of sufficiently powerful instruments until recently. DPCR is less expensive.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02109770 -
Development of Non-invasive Prenatal Test for Microdeletion and Other Genetic Syndromes Based on Cell Free DNA
|
||
Completed |
NCT01925742 -
Study of the Efficacy of New Non-invasive Prenatal Tests for Screening for Fetal Trisomies Using Maternal Blood
|
N/A | |
Completed |
NCT01852708 -
Development of Non-invasive Prenatal Screening Test for Microdeletions Based on Fetal DNA Isolated From Maternal Blood
|
||
Recruiting |
NCT05527652 -
Self-Supporting Nasopharyngeal Airway (ssNPA) Treating Upper Airway Obstruction in Hypotonia
|
N/A | |
Completed |
NCT02278536 -
Multiple Gestation Study
|
||
Completed |
NCT01511458 -
Non-invasive Chromosomal Examination of Trisomy Study
|
N/A | |
Not yet recruiting |
NCT05970965 -
Periodontitis and Inflammation in Children With Down Syndrome/Trisomy 21: Study on Biological Samples
|
N/A | |
Terminated |
NCT03551418 -
Learning by Repetitive Viewing of Peer Modeling Patient Education Videos by Adults With Down Syndrome
|
N/A | |
Completed |
NCT01966991 -
Prenatal Screening for Down Syndrome With DNAFirst
|
N/A | |
Enrolling by invitation |
NCT03559374 -
Study of Vanadis® NIPT for Non-invasive Prenatal Screening of Trisomies (T21, T18 and T13)
|
||
Active, not recruiting |
NCT01725438 -
Non Invasive Prenatal Diagnosis of Trisomy 21 by Genetic Analysis of Circulating Fetal Cells
|
N/A | |
Active, not recruiting |
NCT05981521 -
Paternal Age and Fetal Aneuploidy
|
||
Completed |
NCT05004337 -
Verification of Risk Assignment for Whole Chromosome Using SNP-based NIPT in Vanishing Twin Pregnancies
|
||
Recruiting |
NCT02864108 -
The Crnic Institute Human Trisome Project Biobank
|
||
Completed |
NCT01931644 -
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
|
||
Not yet recruiting |
NCT06200519 -
Assessment of Diastolic Function During the Transitional Period and Infancy Using Serial Echocardiography
|
||
Terminated |
NCT01545674 -
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
|
||
Terminated |
NCT04747275 -
Use of Liquid Stable Levothyroxine in Trisomy 21 Pediatric Patients
|
Phase 4 | |
Completed |
NCT01821300 -
Down Syndrome Metabolic Health Study
|
||
Completed |
NCT00877292 -
A New Prenatal Blood Test for Down Syndrome
|
N/A |